| Not Yet Recruiting | Efficacy of Pulsed Electromagnetic Field and Heparin/Bupivacaine Instillations NCT06013449 | Wake Forest University Health Sciences | N/A |
| Not Yet Recruiting | A Novel Medical System for Quantitative Diagnosis and Personalized Precision Botulinum Neurotoxin Injection in NCT05062902 | HillMed Inc. | EARLY_Phase 1 |
| Not Yet Recruiting | Intravesical Ozone Therapy for Interstitial Cystitis/Bladder Pain Syndrome NCT06863220 | Medipol University | N/A |
| Recruiting | Safety and Efficacy of Aloe Vera in the Management of the Symptoms of Interstitial Cystitis NCT04734106 | Wake Forest University Health Sciences | EARLY_Phase 1 |
| Recruiting | Acupuncture First for IC/BPS NCT06366269 | University Hospitals Cleveland Medical Center | N/A |
| Recruiting | Safety, Efficacy, and Frequency of Administration of VNX001 in the Treatment of Interstitial Cystitis / Bladde NCT06394830 | Vaneltix Pharma, Inc. | Phase 2 |
| Recruiting | Evaluating the Efficacy and Patient Experience of Catheter-Free Intravesical Instillation NCT06719232 | Jahn Ferenc South Pest Teaching Hospital | — |
| Recruiting | Amniotic Membrane Therapy for Interstitial Cystitis/Painful Bladder Syndrome NCT06096597 | David Sheyn | Phase 2 / Phase 3 |
| Withdrawn | Auricular Acupressure Therapy for Patients With IC/BPS NCT05857020 | Wake Forest University Health Sciences | N/A |
| Recruiting | Pain Type and Interstitial Cystitis/Bladder Pain Syndrome Treatment NCT06299683 | Vanderbilt University Medical Center | N/A |
| Enrolling By Invitation | Migraine Medication Effects on Urinary Symptoms NCT06212661 | The Cleveland Clinic | — |
| Completed | Investigation of the Effectiveness of Acupuncture in Patients Diagnosed With Interstitial Cystitis NCT06232200 | Medipol University | N/A |
| Unknown | Assessing the Effectiveness and Safety of Interferon Bladder Infusion for the Treatment of Interstitial Cystit NCT05912946 | West China Hospital | Phase 2 / Phase 3 |
| Recruiting | Safety and Efficacy Study of VNX001 Compared to Its Individual Components (Lidocaine and Heparin) or Placebo i NCT05737121 | Vaneltix Pharma, Inc. | Phase 2 |
| Withdrawn | Supervised Exercise as a Therapeutic Strategy for Interstitial Cystitis/Bladder Pain Syndrome NCT05699551 | Wake Forest University Health Sciences | N/A |
| Recruiting | The Role of Preoperative Immunonutrition on Morbidity and Immune Response After Cystectomy (INCyst Trial) NCT05726786 | Centre Hospitalier Universitaire Vaudois | Phase 3 |
| Terminated | A Phase 2 Study of IW-3300 for the Treatment of Bladder Pain in Subjects With Interstitial Cystitis/Bladder Pa NCT05740007 | Ironwood Pharmaceuticals, Inc. | Phase 2 |
| Active Not Recruiting | Medtronic Hugo™ Robotic Assisted Surgery (RAS) System in Urologic Surgery (Expand URO) NCT05696444 | Medtronic - MITG | N/A |
| Terminated | A Multidisciplinary, Multimodal Bundled Care Approach to Chronic Pelvic Pain NCT05658874 | Jocelyn Fitzgerald | Phase 3 |
| Recruiting | Investigation of PEMF Therapy for Female Patients With IC/BPS NCT05149573 | Wake Forest University Health Sciences | N/A |
| Recruiting | EPPIC: Easing Pelvic Pain Interventions Clinical Research Program NCT05127616 | State University of New York at Buffalo | N/A |
| Withdrawn | Intradetrusor Triamcinolone Injection in the Management of Interstitial Cystitis/Bladder Pain Syndrome NCT05226832 | The University of Texas Medical Branch, Galveston | N/A |
| Completed | What is the Optimal Technique for Hydrodistention? NCT05456308 | University of Michigan | N/A |
| Active Not Recruiting | Transvaginal Botulinum Toxin A for Interstitial Cystitis / Bladder Pain Syndrome NCT05485207 | Stanford University | EARLY_Phase 1 |
| Unknown | Assessment of Urinary Polymerase Chain Reaction (PCR) and Next Generation Sequencing (NGS) Technology in the E NCT05276466 | MicroGenDX | N/A |
| Unknown | Biopsychosocial and Conventional Approach in Bladder Pain Syndrome NCT05155384 | Hacettepe University | N/A |
| Completed | A Study of Pentosan Polysulfate Sodium and the Development of Pigmentary Maculopathy and Pigmentary Retinopath NCT05179460 | Janssen Research & Development, LLC | — |
| Recruiting | Peppermint Oil for the Treatment of Interstitial Cystitis / Bladder Pain Syndrome NCT04845217 | University of Louisville | Phase 1 / Phase 2 |
| Recruiting | Safety of Cultured Allogeneic Adult Umbilical Cord Stem Cells for Peyronie's Disease, ED, and Interstitial Cys NCT05147779 | The Foundation for Orthopaedics and Regenerative Medicine | Phase 1 |
| Terminated | IC PaIN Trial: Interstitial Cystitis Pain Improvement With Naltrexone NCT04313972 | Endeavor Health | Phase 4 |
| Recruiting | Motor Cortical Neuromodulation in Women With Interstitial Cystitis/Bladder Pain Syndrome NCT04734847 | University of Southern California | N/A |
| Unknown | Efficacy and Safety of Low Energy Shock Wave Plus BotulinumToxin A in Treating Patients With Interstitial Cyst NCT05275647 | Buddhist Tzu Chi General Hospital | Phase 2 |
| Completed | Mindfulness and Yoga for Pain With Interstitial Cystitis Evaluation NCT04820855 | University of New Mexico | N/A |
| Completed | Improving Female Sexual Wellness NCT04824820 | Cedars-Sinai Medical Center | N/A |
| Completed | Submucosal Intravesical Injection of Platelet-rich Plasma in the Treatment of Painful Bladder Syndrome NCT06209008 | Ain Shams University | Phase 3 |
| Completed | PEMF Therapy to Treat Interstitial Cystitis/Bladder Pain Syndrome NCT04540887 | Wake Forest University Health Sciences | N/A |
| Withdrawn | The CBD-IC Randomized Controlled Trial: Evaluation of Hemp Cannabidiol SuppositoRies for Pain and Urinary Symp NCT04349930 | University of New Mexico | Phase 1 |
| Unknown | Safety of Human Embryonic Stem Cell (hESC)-Derived Mesenchymal Stem Cells in Interstitial Cystitis NCT04610359 | Asan Medical Center | Phase 1 |
| Withdrawn | A Study to Test if Fremanezumab Reduces Pain in Patients With Interstitial Cystitis-Bladder Pain Syndrome NCT04447729 | Teva Branded Pharmaceutical Products R&D, Inc. | Phase 2 |
| Suspended | Low-dose Naltrexone for Bladder Pain Syndrome NCT04450316 | Stanford University | Phase 2 |
| Completed | The Female Microbiome in Patients Undergoing Bladder Instillation Therapy NCT05414305 | Walter Reed National Military Medical Center | Phase 2 |
| Completed | Bladder Instillations Versus Onabotulinumtoxin A for Treatment of Interstitial Cystitis/Bladder Pain Syndrome NCT04401176 | Walter Reed National Military Medical Center | Phase 2 |
| Completed | Optimizing Psychosocial Treatment of Interstitial Cystitis/Bladder Pain Syndrome NCT04275297 | Vanderbilt University Medical Center | N/A |
| Unknown | Effects of Low-intensity Excoporeal Shock Wave Therapy (LiESWT) on Women With Pelvic Floor Dysfunction NCT05337813 | Kaohsiung Medical University Chung-Ho Memorial Hospital | N/A |
| Completed | PK and Safety of SI-722 in IC/BPS NCT04208087 | Seikagaku Corporation | Phase 1 / Phase 2 |
| Completed | Vestibulodynia: Understanding Pathophysiology and Determining Appropriate Treatments NCT03844412 | Duke University | Phase 2 |
| Completed | Hypnosis for Bladder Pain Syndrome NCT04010513 | University of Pennsylvania | N/A |
| Completed | Intravesical Injection of Dextrose to Improve Lower Urinary Tract Symptoms Caused by Chronic Cystitis NCT04821882 | National Defense Medical Center, Taiwan | N/A |
| Unknown | Platelet Enriched Plasma for Treatment of Interstitial Cystitis NCT04118946 | Mansoura University | Phase 1 / Phase 2 |
| Completed | The Effects of Mindfulness-based Stress Reduction in Interstitial Cystitis Patients NCT03722992 | TriHealth Inc. | N/A |
| Completed | S1P1 Receptor Subtype (S1PR1) Axis in Patients With Interstitial Cystitis (IC) Pain NCT03003845 | St. Louis University | — |
| Completed | Clinical Trial Comparing Two Bladder Instillations for IC/BPS NCT03463915 | Olivia Cardenas-Trowers, M.D. | Phase 3 |
| Completed | Effect of Interferential Electrical Stimulation on Pain Perception and Disability Level on Interstitial Cystit NCT03844581 | Cairo University | N/A |
| Completed | Rapid Molecular Organism Identification and Mixed Flora Antibiotic Resistance Profiling (MixAR) Prospective St NCT03931538 | Pathnostics | N/A |
| Completed | Low Energy Shock Wave for the Treatment of Interstitial Cystitis/Bladder Pain Syndrome (IC/BPS) NCT03619486 | Chang Gung Memorial Hospital | N/A |
| Terminated | Adverse Childhood Experiences in Urogynecologic Patients NCT03480477 | University of New Mexico | — |
| Completed | Genetic and Histopathologic Characteristics of Interstitial Cystitis NCT03523559 | Samsung Medical Center | — |
| Completed | Physiotherapeutic Interventions Applied to the Bladder Pain Syndrome NCT03755375 | University of Sao Paulo General Hospital | N/A |
| Completed | A Study to Investigate Efficacy, Safety, Pharmacodynamics and Pharmacokinetics of ASP6294 in the Treatment of NCT03282318 | Astellas Pharma Europe B.V. | Phase 2 |
| Completed | The Efficacy and Safety of Intravesical Hyaluronic Acid and Chondroitin Sulfate After Transurethral Resection NCT03463499 | Samsung Medical Center | N/A |
| Unknown | Platelet-Rich Plasma (PRP) Injection in Treatment of Interstitial Cystitis NCT03104361 | Buddhist Tzu Chi General Hospital | Phase 1 |
| Completed | Platelet Activating Factor Stability in Urine NCT03103477 | St. Louis University | — |
| Completed | Trans-MAPP II Study of Urologic Chronic Pelvin Pain NCT02898220 | University of Pennsylvania | — |
| Unknown | Efficacy and Safety of 2 Doses of AQX-1125 in Subjects With Interstitial Cystitis / Bladder Pain Syndrome NCT02858453 | Aquinox Pharmaceuticals (Canada) Inc. | Phase 3 |
| Completed | Observational Study of Hunner's Ulcer in Patient With Interstitial Cystitis/Bladder Pain Syndrome NCT02150811 | Asan Medical Center | — |
| Completed | HBOT for Patients With IC/FM (Interstitial Cystitis/Fibromyalgia) NCT03693001 | University of South Florida | N/A |
| Completed | Interstitial Cystitis and Urinary pH NCT03024619 | St. Louis University | — |
| Terminated | Engage 24: Evaluation of the Safety and Effectiveness of URG101 in Subjects With Interstitial Cystitis/Bladder NCT02591199 | Urigen | Phase 2 |
| Completed | Comparing the Effect of Fulguration Versus Fulguration and Hydrodistension in Interstitial Cystitis/Bladder Pa NCT03987594 | Yonsei University | N/A |
| Completed | Evaluation of Intravesical LP08 in Patients With Interstitial Cystitis/Painful Bladder Syndrome NCT01393223 | Lipella Pharmaceuticals, Inc. | Phase 2 |
| Completed | Trans-MAPP Symptom Patterns Study (SPS) NCT02514265 | University of Pennsylvania | — |
| Completed | Pilot Study of Percutaneous Posterior Tibial Nerve Stimulation for the Treatment of IC/PBS NCT02550561 | University of California, Irvine | N/A |
| Terminated | Interstitial Cystitis (IC)-Like Findings With Hydrodistension NCT02547298 | St. Louis University | — |
| Terminated | Use of Preemptive Pudendal Nerve Block Prior to Hydrodistention for the Treatment of Interstitial Cystitis/Pai NCT02517996 | Johns Hopkins University | N/A |
| Completed | Dietary Impact on Urinary pH in Women With Interstitial Cystitis NCT03041194 | St. Louis University | — |
| Completed | Intravesicular Onabotulinumtoxin A in Interstitial Cystitis NCT02297100 | Wake Forest University Health Sciences | Phase 4 |
| Completed | Mindfulness-Based Therapy for Interstitial Cystitis/Bladder Pain Syndrome NCT02457182 | University of New Mexico | N/A |
| Completed | Acupuncture for Female IC/PBSyndrome and Its Effect on the Urinary Microbiome: A Randomized Controlled Trial NCT02232282 | Loyola University | N/A |
| Completed | Intravesical Instillation of Liposome Encapsulated Botulinum Toxin A (Lipotoxin) in Treatment of Interstitial NCT02247557 | Buddhist Tzu Chi General Hospital | Phase 2 |
| Completed | The Efficacy of Biomarker in Patient With Interstitial Cystitis/Painful Bladder Syndrome NCT01985880 | Asan Medical Center | — |
| Completed | Efficacy and Safety of Intravesical Instillations of Botulinum Toxin in TC-3 Gel in IC Patients NCT01997983 | UroGen Pharma Ltd. | Phase 1 / Phase 2 |
| Withdrawn | Microbiome of Urologic Chronic Pelvic Pain Syndrome NCT03027076 | Johns Hopkins University | — |
| Completed | Cyclosporine in Interstitial Cystitis: Efficacy, Safety and Mechanism of Action NCT01990898 | The Cleveland Clinic | Phase 2 |
| Completed | Efficacy and Safety of AQX-1125 in IC/BPS NCT01882543 | Aquinox Pharmaceuticals (Canada) Inc. | Phase 2 |
| Terminated | The Efficacy of Additional Intravesical Instillation of Hyaluronic Acid/Chondroitin Sulfate to Transurethral R NCT01813565 | Asan Medical Center | N/A |
| Terminated | Safety, Tolerability and Efficacy Study of LiRIS® 400 mg in Women With Interstitial Cystitis NCT01824303 | Allergan | Phase 2 |
| Completed | Intravesical Botulinum Toxin A Injections in Treatment of Interstitial Cystitis Refractory to Conventional Tre NCT01969773 | Buddhist Tzu Chi General Hospital | Phase 2 |
| Completed | Therapeutic Effects of Endoscopic Ablation of Hunner Lesions in Interstitial Cystitis/ Bladder Pain Syndrome P NCT03468530 | Samsung Medical Center | — |
| Terminated | Efficacy of Gralise® for Chronic Pelvic Pain NCT01678911 | Shirley Ryan AbilityLab | Phase 4 |
| Completed | Intravesical Liposomes for Interstitial Cystitis/Painful Bladder Syndrome (IC/PBS) NCT01731470 | Kenneth Peters, MD | N/A |
| Unknown | Bladder Thermal Distention for Patients With Interstitial Cystitis / Painful Bladder Syndrome NCT01838486 | Assaf-Harofeh Medical Center | N/A |
| Completed | Microbiomes of Pelvic Pain NCT01738464 | Northwestern University | — |
| Completed | Intranasal Ketorolac Tromethamine (Sprix) for Acute Pain of Interstitial Cystitis Flare of Pain NCT02000401 | Citrus Valley Medical Research, Inc. | Phase 4 |
| Completed | Safety Study of Single Intravesical Doses of TTI-1612 in Women With Interstitial Cystitis/Bladder Pain Syndrom NCT01559961 | Trillium Therapeutics Inc. | Phase 1 |
| Terminated | Double-Blind Placebo Controlled Study of Safety,Tolerability, and Efficacy of LiRIS® in Women With Interstitia NCT01475253 | Allergan | Phase 2 |
| Completed | Bladder Capacity as Objective Measure of Intravesical Treatment of Newly Diagnosed IC NCT05223244 | Endeavor Health | Phase 4 |
| Unknown | Efficacy of Botulinum Toxin Type A in Patients With Bladder Pain Syndrome/Intersticial Cystitis and Hunners' L NCT01437579 | Moscow State University of Medicine and Dentistry | Phase 2 |
| Withdrawn | Evaluate The Effectiveness Of Fospropofol (Lusedra®) For Induction Of Anesthesia NCT01378754 | Grace Shih, MD | N/A |
| Unknown | Clinical Efficacy of Changing the InterStim® Parameters in Patients With Interstitial Cystitis/Painful Bladder NCT01312259 | Pelvic and Sexual Health Institute | Phase 4 |
| Completed | Prospective Trial Comparing Response to Hyperbaric Oxygen Treatment in Patients With Interstitial Cystitis NCT01479725 | Kenneth Peters, MD | Phase 2 |
| Completed | Efficacy Study of Adalimumab to Treat Interstitial Cystitis NCT01295814 | ICStudy, LLC | Phase 3 |
| Unknown | Female Chronic Pelvic Pain NCT01255345 | Copenhagen University Hospital at Herlev | — |
| Unknown | Autonomic Response During Cystodistension in Patients Suspected of Having Interstitial Cystitis NCT01301365 | Assaf-Harofeh Medical Center | — |
| Completed | OXN PR vs Placebo in Opioid-naive Subjects Suffering From Severe Pain Due to Bladder Pain Syndrome (BPS) NCT01197261 | Mundipharma Research GmbH & Co KG | Phase 2 |
| Completed | Intravesical Liposomes for Ulcerative Cystitis NCT01083979 | Kenneth Peters, MD | N/A |
| Completed | Safety Study of LiRIS in Interstitial Cystitis (IC) Patients NCT01150565 | Allergan | Phase 1 |
| Completed | Intranasal Oxytocin for the Treatment of Pain Associated With Interstitial Cystitis NCT00919802 | University of Alabama at Birmingham | Phase 4 |
| Completed | Assessing Chronic Pain Conditions in Patients (Pts) With and Without (w&wo) Interstitial Cystitis NCT01138800 | Corewell Health East | — |
| Completed | Usefulness of Dexmedetomidine on Post-operative Pain Management in Patients With Interstitial Cystitis NCT01195116 | University of Rochester | Phase 4 |
| Terminated | MAPP Investigation of Pelvic Floor-Brain Neurobiologic Axis in IC/IBS and IBS NCT01280864 | Augusta University | — |
| Terminated | Prospective Trial Comparing Intravesical Chondroitin Sulphate 2% and DMSO in the Treatment of PBS/Interstitial NCT04268810 | National Multiple Sclerosis Center | Phase 4 |
| Unknown | Comparative Study Between Hyperbaric Therapy and Intravesical Dimethyl Sulfoxide Instillation for Interstitial NCT01069263 | Assaf-Harofeh Medical Center | N/A |
| Completed | Chronic Pelvic Pain Study of Individuals With Diagnoses or Symptoms of Interstitial Cystitis and/ or Chronic P NCT01098279 | University of Pennsylvania | — |
| Unknown | Osteopathic Manipulation for Female Interstitial Cystitis Patients With Sacroiliac Joint Dysfunction NCT01311479 | Pelvic and Sexual Health Institute | N/A |
| Completed | Urinary Biomarkers Characteristic to Interstitial Cystitis NCT00971568 | Corewell Health East | — |
| Completed | Efficacy and Safety Study of Uracyst to Treat Interstitial Cystitis/Painful Bladder Syndrome NCT00919113 | Watson Pharmaceuticals | Phase 2 |
| Completed | Omalizumab in Interstitial Cystitis/Bladder Pain Syndrome NCT01294878 | Fondazione IRCCS Policlinico San Matteo di Pavia | Phase 3 |
| Completed | Osteopathic Manipulation Therapy in the Treatment of Interstitial Cystitis NCT00873171 | CAMC Health System | — |
| Withdrawn | Effect of Intravesical Lidocaine on Urodynamic and Symptomatic Parameters of Interstitial Cystitis NCT00823030 | Northwell Health | N/A |
| Completed | Effect of Repetitive Transcranial Direct Current Stimulation (tDCS) on Chronic Pelvic Pain NCT00554320 | Summa Health System | N/A |
| Completed | Correlating Ic/Pbs Symptoms With Urine Biomarkers NCT00817388 | Corewell Health East | — |
| Completed | An Effectiveness And Safety Study Of PD 0299685 For The Treatment Of Symptoms Associated With Interstitial Cys NCT00739739 | Pfizer | Phase 2 |
| Completed | Physical Therapy in Women With Interstitial Cystitis NCT00733603 | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | N/A |
| Completed | Relationship of Interstitial Cystitis to Vulvodynia NCT00546858 | Corewell Health East | — |
| Completed | A Pilot Clinical Investigation of the Efficacy and Safety of Uracyst® Versus Placebo in Patients With Intersti NCT00527917 | Watson Pharmaceuticals | Phase 2 |
| Terminated | Study of URG101 in Painful Bladder Syndrome and Interstitial Cystitis NCT00517868 | Urigen | Phase 2 |
| Completed | Proteomics of Cerebrospinal Fluid in Chronic Fatigue Syndrome NCT00810329 | Georgetown University | — |
| Completed | Quantitative Studies of Urinary Bladder Sensation NCT00903435 | Timothy Ness, MD | — |
| Completed | Sacral Neuromodulation in Patients With IC NCT00590473 | Drexel University College of Medicine | N/A |
| Terminated | A Randomized Multicenter Double-Blind CT to Evaluate the Efficacy and Safety of Mycophenolate Mofetil . . . NCT00451867 | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | Phase 3 |
| Recruiting | Genetic Study of Chronic Prostatitis/Chronic Pelvic Pain Syndrome (CP/CPPS) NCT00499317 | Boston Children's Hospital | — |
| Completed | Study of Biomarkers and the Relaxation Response Using Guided Imagery in Women With IC NCT00420550 | Corewell Health East | Phase 2 |
| Completed | Physical Therapy Trial for Pelvic Pain NCT00434343 | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | N/A |
| Completed | The Women's Urology Center/WISH Database Project NCT00379002 | Corewell Health East | — |
| Terminated | Trial Comparing Intravesical Cocktail With Intravesical Dimethyl Sulfoxide (DMSO) in Painful Bladder Syndrome/ NCT00317070 | Nova Scotia Health Authority | Phase 2 |
| Recruiting | Identifying Genetic Causes of IC/BPS NCT00389142 | Boston Children's Hospital | — |
| Completed | Study of U101 for Bladder Pain and/or Urgency NCT00256542 | Urigen | Phase 2 |
| Terminated | Analysis of Expression of Nitric Oxide Syntheses and Their Functional Role in Human Urothelium NCT00253006 | Copenhagen University Hospital at Herlev | — |
| Completed | URACYST® For the Treatment of GAG Deficient Interstitial Cystitis NCT00150488 | Dr. J. Curtis Nickel | N/A |
| Completed | Phase II Study Efficacy and Safety of Two Dosing Regimens of MN-001 in Patients With Interstitial Cystitis NCT00295854 | MediciNova | Phase 2 |
| Completed | Efficacy of Amitriptyline for Painful Bladder Syndrome (PBS) NCT00124306 | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | Phase 3 |
| Completed | Diagnosis of Bladder Pain Syndrome / Interstitial Cystitis NCT03023241 | Cantonal Hospital, Frauenfeld | N/A |
| Unknown | Acupuncture for the Treatment of Interstitial Cystitis (IC) Symptoms NCT00094874 | The Mary Elizabeth Groff Surgical Medical Research and Education Charitable Trust | Phase 3 |
| Completed | Genetics of Interstitial Cystitis NCT00237081 | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | — |
| Completed | Botox as a Treatment for Interstitial Cystitis in Women NCT00194610 | University of Washington | Phase 4 |
| Completed | Impact Of Sacral Neuromodulation On Urine Markers For Interstitial Cystitis (IC) NCT00704457 | Kenneth Peters, MD | — |
| Completed | Urology Database to Evaluate Clinical Information and Improve Patient Care. NCT00376298 | Kenneth Peters, MD | — |
| Terminated | Effectiveness and Safety Study of Pentosan Polysulfate Sodium for the Treatment of Interstitial Cystitis NCT00086684 | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | Phase 4 |
| Completed | Interstitial Cystitis NCT00056251 | ICOS Corporation | Phase 2 |
| Completed | Phase I/II Randomized, Placebo-Controlled Study of Capsaicin for Interstitial Cystitis and Vulvar Vestibulitis NCT00004316 | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | Phase 1 / Phase 2 |